Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Dasatinib

    Client Email Product

    Dasatinib

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    INTERMEDIATES

    DOSSIERs // Finished Dosage Formulations

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    62
    US DMFs Filed

    US DMFs Filed

    28
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    4
    Other Certificates

    Other Certificates

    9
    Other Suppliers

    Other Suppliers

    43
    API REF. PRICE (USD / KG)
    7,976

    API Market Place

    8
    INTERMEDIATES
    19
    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    35
    Europe

    Europe

    37
    Canada

    Canada

    22
    Australia

    Australia

    168
    South Africa

    South Africa

    4
    Uploaded Dossiers

    Uploaded Dossiers

    44
    GLOBAL SALES (USD Million)

    U.S. Medicaid

    2,790.00

    Annual Reports

    2,275.00

    FDF Market Place

    6
    EXCIPIENTS
    148
    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    66

    USFDA Exclusivities

    24
    DIGITAL CONTENT

    Blog #PharmaFlow

    2

    News

    40
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    5
    SERVICES
    1
    Full View ScreenFull Screen View
    Teva's Generic Dasatinib Receives Approval in the U.S.
    Teva's Generic Dasatinib Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211094

    FDA
    06 Dec 2023
    Share Share
    Teva Pharma Generic Dasatinib Receives Tentative Approval in US
    Teva Pharma Generic Dasatinib Receives Tentative Approval in US

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211094

    FDA
    01 Jul 2022
    Share Share
    Accord Healthcare Dasatinib Receives Approval in Europe
    Accord Healthcare Dasatinib Receives Approval in Europe

    https://www.ema.europa.eu/en/documents/overview/dasatinib-accord-epar-medicine-overview_en.pdf

    EMA
    10 Jun 2022
    Share Share
    Alembic's Generic Dasatinib Receives Approval in the U.S.
    Alembic's Generic Dasatinib Receives Approval in the U.S.

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216261

    FDA
    09 Jun 2022
    Share Share
    Bristol-Myers Sues XSpray to Block Copies of Blockbuster Sprycel
    Bristol-Myers Sues XSpray to Block Copies of Blockbuster Sprycel

    https://news.bloomberglaw.com/health-law-and-business/bristol-myers-sues-xspray-to-block-copies-of-blockbuster-sprycel

    BLOOMBERG LAW
    25 Feb 2022
    Share Share
    Health Canada Issues Recall of Reddy-Dasatinib: out of specification
    Health Canada Issues Recall of Reddy-Dasatinib: out of specification

    https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-reddy-dasatinib-out-of-specification-1643777561.pdf

    HEALTH CANADA
    02 Feb 2022
    Share Share
    ICR researchers find drug combination to treat brain cancer in children
    ICR researchers find drug combination to treat brain cancer in children

    https://www.pharmaceutical-technology.com/news/icr-researchers-brain-cancer-children/

    PHARMACEUTICAL-TECHNOLOGY
    08 Nov 2021
    Share Share
    Xspray reports positive results from a study with dasatinib during omeprazole
    Xspray reports positive results from a study with dasatinib during omeprazole

    https://xspraypharma.com/en/modular_finance_pressmeddelande/xspray-pharma-reports-positive-results-from-a-study-with-dasatinib-during-omeprazole-treatment/

    PRESS RELEASE
    30 Dec 2020
    Share Share
    Shilpa Medicare launches branded generic anticancer drug Dasatinib
    Shilpa Medicare launches branded generic anticancer drug Dasatinib

    http://www.pharmabiz.com/NewsDetails.aspx?aid=123671&sid=2

    PHARMABIZ
    23 Apr 2020
    Share Share
    Dr Reddy's launches generic cancer drug in India
    Dr Reddy's launches generic cancer drug in India

    https://www.moneycontrol.com/news/business/dr-reddys-launches-generic-cancer-drug-in-india-5138521.html

    MONEYCONTROL
    12 Apr 2020
    Share Share
    Marrying CRISPR with immuno-oncology to defeat remote tumors
    Marrying CRISPR with immuno-oncology to defeat remote tumors

    https://www.fiercebiotech.com/research/marrying-crispr-immuno-oncology-to-defeat-remote-tumors

    Arlene Weintraub FIERCE BIOTECH
    14 Oct 2019
    Share Share
    EC OKs expanded use for Bristol-Myers' Sprycel
    EC OKs expanded use for Bristol-Myers' Sprycel

    https://seekingalpha.com/news/3431582-ec-oks-expanded-use-bristol-myers-sprycel

    Douglas W. House SEEKING ALPHA
    11 Feb 2019
    Share Share
    Bristol-Myers Squibb’s Sprycel (dasatinib) Tablets Approved
    Bristol-Myers Squibb’s Sprycel (dasatinib) Tablets Approved

    https://www.businesswire.com/news/home/20190102005607/en

    BUSINESSWIRE
    03 Jan 2019
    Share Share
    Sprycel combo gets FDA approval
    Sprycel combo gets FDA approval

    http://www.pharmatimes.com/news/sprycel_combo_gets_fda_approval_1273743

    Anna Smith PHARMA TIMES
    03 Jan 2019
    Share Share
    EMA Assessment of Incyte Biosciences' Iclusig (ponatinib) & Procedural steps
    EMA Assessment of Incyte Biosciences' Iclusig (ponatinib) & Procedural steps

    https://www.ema.europa.eu/documents/procedural-steps-after/iclusig-epar-procedural-steps-taken-scientific-information-after-authorisation_en-0.pdf

    EMA
    10 Oct 2018
    Share Share
    EMA Assessmt & Procedural Steps for Incyte's Iclusig (ponatinib)
    EMA Assessmt & Procedural Steps for Incyte's Iclusig (ponatinib)

    https://www.ema.europa.eu/documents/scientific-conclusion/iclusig-h-c-psusa-00010128-201712-epar-scientific-conclusions-grounds-variation-terms-marketing_en.pdf

    EMA
    10 Oct 2018
    Share Share
    Xspray Pharma announces +ve data from clinical bioE study with HyNap-Dasa
    Xspray Pharma announces +ve data from clinical bioE study with HyNap-Dasa

    http://www.pharmabiz.com/NewsDetails.aspx?aid=111132&sid=2

    PHARMABIZ
    11 Sep 2018
    Share Share
    Xspray Pharma Announces +ve Clinical Data for Candidate HyNap-Dasa
    Xspray Pharma Announces +ve Clinical Data for Candidate HyNap-Dasa

    https://www.prnewswire.com/news-releases/xspray-pharma-announces-positive-clinical-data-for-its-lead-product-candidate-hynap-dasa-300709365.html

    PR NEWSWIRE
    10 Sep 2018
    Share Share
    FDA Accepts Bristol-Myers Squibb’s Application for Sprycel
    FDA Accepts Bristol-Myers Squibb’s Application for Sprycel

    https://www.rdmag.com/news/2018/08/fda-accepts-bristol-myers-squibbs-application-sprycel

    RDMAG
    01 Sep 2018
    Share Share
    EC approves expanded indication for Sprycel
    EC approves expanded indication for Sprycel

    https://www.thepharmaletter.com/article/ec-approves-expanded-indication-for-sprycel

    PHARMA LETTER
    06 Jul 2018
    Share Share
    AZ’ lung cancer drug Tagrisso backed for first-line use
    AZ’ lung cancer drug Tagrisso backed for first-line use

    http://www.pharmatimes.com/news/az_lung_cancer_drug_tagrisso_backed_for_first-line_use_1233742

    Selina McKee PHARMA TIMES
    30 Apr 2018
    Share Share
    U.S. Food and Drug Administration Expands Approval of Sprycel® (dasatinib)
    U.S. Food and Drug Administration Expands Approval of Sprycel® (dasatinib)

    http://www.businesswire.com/news/home/20171110005191/en/U.S.-Food-Drug-Administration-Expands-Approval-Sprycel%C2%AE/?feedref=JjAwJuNHiystnCoBq_hl-WFAllVCLJFCqzlmaJ8DKHU4plfPZtlGYRDUHCSmgbii6XkLWuQZD-HgGRnjQvCyg3iCfEFIaJW7-otp9V1XQiK2eHTJy3ZqOEt7kKgLu20J

    BUSINESSWIRE
    10 Nov 2017
    Share Share
    Drug Helps Some Kids With Rare Type of Leukemia
    Drug Helps Some Kids With Rare Type of Leukemia

    http://www.webmd.com/cancer/news/20170605/cancer-drug-helps-some-kids-with-rare-type-of-leukemia?src=RSS_PUBLIC

    Robert Preidt WEBMD
    05 Jun 2017
    Share Share
    CML patients in England win access to Incyte’s Iclusig
    CML patients in England win access to Incyte’s Iclusig

    http://www.pharmatimes.com/news/cml_patients_in_england_win_access_to_incytes_iclusig_1192128

    Selina McKee FIERCE BIOTECH
    03 May 2017
    Share Share
    Global move against Roche brings focus back on cancer drug prices
    Global move against Roche brings focus back on cancer drug prices

    http://www.thehindubusinessline.com/companies/article9547318.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication

    AESHA DATTA THE HINDU BUSINESS LINE
    16 Feb 2017
    Share Share
    Bristol's earnings at risk as court shuts down Sprycel patent in Europe
    Bristol's earnings at risk as court shuts down Sprycel patent in Europe

    http://www.fiercepharma.com/pharma/court-shuts-down-bristol-s-eu-sprycel-patent-appeal-and-eps-could-suffer-analyst

    Carly Helfand FIERCE PHARMA
    03 Feb 2017
    Share Share
    NICE backs BMS leukaemia drug Sprycel
    NICE backs BMS leukaemia drug Sprycel

    http://www.pmlive.com/pharma_news/nice_backs_bms_leukaemia_drug_sprycel_1177624

    Rebecca Clifford PMLIVE
    21 Nov 2016
    Share Share
    NICE approves three quarters of CDF group 1 drugs
    NICE approves three quarters of CDF group 1 drugs

    http://www.pharmatimes.com/news/nice_approves_three_quarters_of_cdf_group_1_drugs_1177594

    G Underwood PHARMATIMES
    18 Nov 2016
    Share Share
    NICE approves three quarters of CDF drugs for routine NHS use
    NICE approves three quarters of CDF drugs for routine NHS use

    http://www.europeanpharmaceuticalreview.com/45598/news/industry-news/nice-cdf-drugs-routine-nhs-use/?

    EUROPEAN PHARMACEUTICAL
    17 Nov 2016
    Share Share
    Roche, Bristol-Myers cut cancer drug prices to win UK approval
    Roche, Bristol-Myers cut cancer drug prices to win UK approval

    http://uk.reuters.com/article/us-britain-cancer-bristolmyers-roche-idUKKBN13C006

    Ben Hirschler REUTERS
    16 Nov 2016
    Share Share
    BCR-ABL Tyrosine Kinase Inhibitors - Risk of Hepatitis B Reactivation
    BCR-ABL Tyrosine Kinase Inhibitors - Risk of Hepatitis B Reactivation

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-eng.php

    HEALTH CANADA
    06 May 2016
    Share Share
    Health Canada Require Updated Warning on Gleevec Labeling for Brand and Generics
    Health Canada Require Updated Warning on Gleevec Labeling for Brand and Generics

    http://twofourinsight.com/health-canadarequires-warning-gleevec-labeling-brand-generics/

    TWOFOUR INSIGHT
    05 May 2016
    Share Share
    BCR-ABL Tyrosine Kinase Inhibitors
    BCR-ABL Tyrosine Kinase Inhibitors

    http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2016/58222a-eng.php

    HEALTH CANADA
    04 May 2016
    Share Share
    Two Indian generics makers end battle to copy drugs amid patent debate
    Two Indian generics makers end battle to copy drugs amid patent debate

    http://www.reuters.com/article/us-india-medicine-patents-idUSKCN0X918Z

    REUTERS
    13 Apr 2016
    Share Share
    Medicine to treat cancer wins indication for leukemia
    Medicine to treat cancer wins indication for leukemia

    http://portal.anvisa.gov.br/wps/content/anvisa+portal/anvisa/sala+de+imprensa/menu+-+noticias+anos/201616/medicamento+para+tratar+cancer+ganha+indicacao+para+leucemia

    ANVISA
    17 Mar 2016
    Share Share
    US FDA approves product labelling update for Sprycel to include efficacy and safety data
    US FDA approves product labelling update for Sprycel to include efficacy and safety data

    http://www.pharmabiz.com/NewsDetails.aspx?aid=90013&sid=2

    PHARMABIZ
    16 Aug 2015
    Share Share
    Indian court upholds BMS Sprycel patent, but list of challengers grows
    Indian court upholds BMS Sprycel patent, but list of challengers grows

    http://www.fiercepharmaasia.com/story/indian-court-upholds-bms-sprycel-patent-list-challengers-grows/2015-07-07

    EJ Lane FIERCE PHARMA ASIA
    08 Jul 2015
    Share Share
    Delhi High Court upholds BMS’ patent for cancer drug Dasatinib
    Delhi High Court upholds BMS’ patent for cancer drug Dasatinib

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-high-court-upholds-bms-patent-for-cancer-drug-dasatinib/articleshow/47952559.cms

    Divya Rajagopal THE ECONOMIC TIMES
    05 Jul 2015
    Share Share
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.
    Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

    http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30

    Eric Palmer FIERCE PHARMA MFG
    02 May 2015
    Share Share
    Compulsory Licensing A Recognised Instrument Says WIPO Chief Francis Gurry
    Compulsory Licensing A Recognised Instrument Says WIPO Chief Francis Gurry

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/compulsory-licensing-a-recognised-instrument-says-wipo-chief-francis-gurry/articleshow/45892034.cms

    Bureau THE ECONOMIC TIMES
    15 Jan 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search